These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20926473)

  • 41. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests.
    Collazos J; Mendarte U; De Miguel J
    Gastroenterol Clin Biol; 1993; 17(2):79-82. PubMed ID: 8500713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
    Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
    Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical predictors of fibrosis in patients with chronic liver disease.
    Stepanova M; Aquino R; Alsheddi A; Gupta R; Fang Y; Younossi Z
    Aliment Pharmacol Ther; 2010 May; 31(10):1085-94. PubMed ID: 20175770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
    Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
    Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serum protein electrophoresis in Laennec's and postnecrotic cirrhosis].
    Mincis M; Guimarães RX; Chaud Sobrinho J; Wachslicht H
    AMB Rev Assoc Med Bras; 1972 Nov; 18(11):447-52. PubMed ID: 4539872
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease.
    Kawada T
    J Gastroenterol; 2013 May; 48(5):671-2. PubMed ID: 23440555
    [No Abstract]   [Full Text] [Related]  

  • 49. Hematocrit levels and red blood cell indices in patients with nonalcoholic fatty liver disease.
    Issa D; Albeldawi M; Lopez R; Alkhouri N
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):363-4. PubMed ID: 24463543
    [No Abstract]   [Full Text] [Related]  

  • 50. Is M65 really better than M30 as a biomarker of hepatic fibrosis?
    Yilmaz Y; Kurt R
    Hepatology; 2012 Feb; 55(2):654; author reply 654-5. PubMed ID: 22161311
    [No Abstract]   [Full Text] [Related]  

  • 51. [Fetuin-A, alpha2-Heremans-Schmid glycoprotein (AHSG)].
    Kumon Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():856-8. PubMed ID: 20960885
    [No Abstract]   [Full Text] [Related]  

  • 52. Plasma proteins present in human cortical bone: enrichment of the alpha2HS-glycoprotein.
    Triffitt JT
    Calcif Tissue Res; 1976 Nov; 22(1):27-33. PubMed ID: 1000340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is hematocrit really associated with fibrosis in patients with nonalcoholic steatohepatitis?
    Kayadibi H; Sertoglu E; Uyanik M
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):814-5. PubMed ID: 24901828
    [No Abstract]   [Full Text] [Related]  

  • 54. [The state of the blood coagulation system in children with cirrhosis of the liver].
    Ryzhkova LA
    Pediatriia; 1968 Feb; 47(2):29-33. PubMed ID: 5729978
    [No Abstract]   [Full Text] [Related]  

  • 55. After goodbye? Dead hepatocytes as a biomarker for fibrosis and steatohepatitis.
    Choi S; Diehl AM
    Hepatology; 2012 Feb; 55(2):333-5. PubMed ID: 22183709
    [No Abstract]   [Full Text] [Related]  

  • 56. [Blood lymphocytes in liver diseased patients].
    Ruhl E; Dufey K
    Klin Wochenschr; 1968 Oct; 46(20):1113-4. PubMed ID: 4178907
    [No Abstract]   [Full Text] [Related]  

  • 57. Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease.
    Abenavoli L; Milic N; Luigiano C
    Minerva Med; 2014 Apr; 105(2):175. PubMed ID: 24727882
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunoelectrophoretic picture of the blood serum in liver cirrhosis].
    BRATKOWSKA-SENIOW B; CHECINSKA Z; SZYMANSKA J
    Pol Arch Med Wewn; 1961; 31():929-33. PubMed ID: 13872548
    [No Abstract]   [Full Text] [Related]  

  • 59. RELATION of fatty liver to hepatic fibrosis.
    Nutr Rev; 1955 Oct; 13(10):297-9. PubMed ID: 13266225
    [No Abstract]   [Full Text] [Related]  

  • 60. [Liver cirrhosis and serum proteins (with special reference to atypical cases)].
    WEWALKA F
    Wien Z Inn Med; 1961 Mar; 42():85-134 contd. PubMed ID: 13784683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.